ARAY 財務： Accuray Inc AI 分析

首頁

股票

ARAY

財務狀況

ARAY 財務

Accuray Inc

$0.38

1.34%

$0

收盤價：Mar 24, 16:00:00 GMT-4

$0.38

盤前：Mar 25, 05:56:10 GMT-4

概觀預測收益股利財務狀況

關鍵數據

前收市價

$0.3794

開盤價

$0.3754

當日範圍

$0.37 - $0.3911

52週區間

$0.33 - $2.1

交易量

820.2K

平均成交量

1.1M

股息收益率

每股盈餘 (TTM)

-0.30

市值

$45.6M

什麼是 ARAY？

Accuray, Inc. is a radiation therapy company, which engages in manufacturing medical equipment. The company is headquartered in Madison, Wisconsin and currently employs 990 full-time employees. The company went IPO on 2007-02-08. The firm develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.

功能特性

資源

市場

收入

資產負債表

現金流量

年度

每季

ARAY 收入

財務數據以百萬美元計。會計年度為二月至一月。

Breakdown	TTM	06/30/2025	06/30/2024	06/30/2023	06/30/2022	06/30/2021
營收	436	458	446	447	429	396
營收年增率 (YoY)	-4%	3%	0%	4%	8%	4%
營收成本	315	311	303	293	270	236
毛利	121	146	143	154	160	159
銷售、一般及管理費用	86	91	91	94	94	84
研發	44	47	48	57	57	52
營業費用	130	139	140	151	151	137
其他非營業收入 (費用)	0	0	0	0	0	1
稅前淨利	-33	1	-11	-6	-2	-4
所得稅費用	2	2	3	2	3	1
淨利	-35	-1	-15	-9	-5	-6
淨利成長	775%	-93%	67%	80%	-17%	-300%
稀釋後流通股數	120.97	102.76	98.27	94.9	92.1	92
股數年變動 (YoY)	17%	5%	4%	3%	0%	2%
每股盈餘 (稀釋)	-0.29	-0.01	-0.15	-0.1	-0.06	-0.07
每股盈餘成長率	564%	-90%	57.99%	67%	-14%	-275%
自由現金流	-2	-1	-15	2	-7	36
每股自由現金流	--	--	--	--	--	--
毛利率	27.75%	31.87%	32.06%	34.45%	37.29%	40.15%
營業利益率	-1.83%	1.52%	0.67%	0.44%	1.86%	5.55%
淨利率	-8.02%	-0.21%	-3.36%	-2.01%	-1.16%	-1.51%
自由現金流利潤率	-0.45%	-0.21%	-3.36%	0.44%	-1.63%	9.09%
EBITDA	-1	13	8	6	13	28
EBITDA 利潤率	-0.22%	2.83%	1.79%	1.34%	3.03%	7.07%
EBITDA 中的折舊與攤銷	7	6	5	4	5	6
EBIT	-8	7	3	2	8	22
EBIT 利潤率	-1.83%	1.52%	0.67%	0.44%	1.86%	5.55%
有效稅率	-6.06%	200%	-27.27%	-33.33%	-150%	-25%

Follow-Up Questions

Báo cáo tài chính chính của Accuray Inc là gì?



Theo báo cáo tài chính mới nhất (Form-10K), Accuray Inc có tổng tài sản là $470, lợi nhuận ròng 損失 là $-1

Tỷ lệ tài chính chính của ARAY là gì?



Tỷ lệ thanh khoản của Accuray Inc là 1.2, tỷ suất lợi nhuận ròng là -0.21, doanh thu trên mỗi cổ phiếu là $4.45.

Doanh thu của Accuray Inc được phân bổ theo phân khúc hoặc khu vực địa lý như thế nào?



Accuray Inc 最大收入來源為 Oncology Systems Products，在最近的收益報告中收入為 234,164,000。就地區而言，Europe, Middle East, India and Africa 是 Accuray Inc 的主要市場，收入為 168,611,000。

Accuray Inc có lợi nhuận không?



無, theo báo cáo tài chính mới nhất, Accuray Inc có lợi nhuận ròng 損失 là $-1

Accuray Inc có nợ không?



是的, Accuray Inc có nợ là 389

Accuray Inc có bao nhiêu cổ phiếu đang lưu hành?



Accuray Inc có tổng cộng 112.64 cổ phiếu đang lưu hành

Accuray Inc (ARAY) 財務

ARAY 股價走勢圖